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Background/aim: Since the nature of ischemia/reperfusion (IR)-induced tissue damage is multifactorial and complex, in the current
study, the effects of multiple treatment strategies via concomitant administration of erythropoietin (EPO) and N-acetylcysteine (NAC)
with an ischemic preconditioning (IPC) regimen on renal IR injury were examined.
Materials and methods: Thirty male Wistar rats were subjected to bilateral occlusion of the renal pedicles for 50 min followed by
reperfusion. EPO (1000 IU/kg) was administered for 3 days, as well as IPC before the IR and NAC (150 mg/kg) administration for 4 days
after IR. The animals were randomly allocated into 6 groups (n = 5): sham, IR, EPO+IR, IPC+IR, NAC+IR, and EPO+IPC+NAC+IR.
Kidney tissues and blood samples were obtained for oxidative stress, proinflammatory cytokines, and renal functional evaluations.
Results: IR caused significant inflammatory response, oxidative stress, and reduced renal function. Treatment with EPO, IPC, and NAC
or a combination of two of them attenuated renal dysfunction and reduced the oxidative stress and inflammatory markers. Rats treated
with the combination of EPO, IPC, and NAC showed a higher degree of protection compared to the other groups.
Conclusion: These results showed that concomitant administration of EPO and IPC along with posttreatment NAC may have additive
beneficial effects on kidney IR injury during IR-induced acute renal failure.
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1. Introduction
Acute renal failure as a result of ischemia/reperfusion (IR)
injury refers to a pathophysiological process by which
renal ischemic cells become more damaged following the
restoration of the blood supply [1]. IR injury as the main
cause of acute renal failure occurs subsequent to different
kinds of acute stress, including kidney vascular surgery,
transplantation, septic shock, trauma, extracorporeal
shock wave lithotripsy, or resuscitation [2]. In addition,
the complex association of this pathological phenomenon
with inﬂammation makes the IR injury an important risk
factor for the progression of chronic kidney disease [3].
Inﬂammation, apoptosis, necrosis, and the formation
of reactive oxygen species (ROS) have been suggested
to be involved in the pathogenesis of IR injury [4]. The
modulation of inﬂammatory response, inhibition of
apoptosis, and amelioration of oxidative stress confer
an advantage in the prevention and treatment of renal
IR injury [5]. Several interventional mechanisms and

pharmacological agents have been reported to protect
renal tissues from IR injury. Since the nature of IR-induced
tissue damage is complex, the protection mechanisms must
be multifactorial. Thus far, a variety of mechanisms have
been discussed, including free radical scavengers, reduced
production of free radicals, inhibition of inflammation,
and reduction of lipid peroxidation [6].
Erythropoietin (EPO) is a hematopoietic growth
factor released by the kidney in response to hypoxia,
inﬂammation, and cell death [7]. EPO has been suggested
to exert antioxidant, antiinﬂammatory, and antiapoptotic
effects against kidney IR injury [7,8].
Ischemic preconditioning (IPC), which comprises
short sublethal cycles of IR prior to the prolonged ischemic
insult, provides protection against renal IR injury [9]. IPC
has been shown to have a strong renoprotective effect
due to its antiapoptosis/necrosis, antiinflammatory, and
antioxidant properties [10]. N-acetylcysteine (NAC) is able
to replenish glutathione stores and scavenge oxygen free
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radicals. NAC has also been reported to attenuate renal IR
injury by inhibiting oxidative stress [11]. However, there
are no studies examining the effect of the combination
of EPO and NAC with the IPC method on renal IR
injury. Since the nature of IR-induced tissue damage is
multifactorial and complex, the aim of present study was
to investigate the effect of concomitant administration of
EPO and NAC with an IPC regimen on renal IR injury.
2. Materials and methods
2.1. Animals and diet
Male albino Wistar rats (220–270 g), from Tehran
University of Medical Sciences, School of Medicine
Laboratories (Iran, Tehran), were used in this study.
They were maintained in an air-filtered, temperatureconditioned (25 ± 2 °C), and light-controlled (12:12 light/
dark photoperiod) room. The rats were fed standard
commercial pellets and water ad libitum. All of the
experimental procedures were performed based on the
Protection of Animals Act after approval.
2.2. Animal preparation
The rats were anesthetized via intraperitoneal
administration of ketamine hydrochloride (50 mg/kg)
and xylazine (10 mg/kg). After anesthesia, the surgical
procedure for the induction of kidney IR injury was
performed. Briefly, a midline abdominal incision was
made, with which the abdominal cavity was fully exposed.
The bilateral renal pedicles were carefully isolated and
clamped using nontraumatic microvascular clamps.
Throughout the induction of the kidney IR injury, the
body temperature was kept between 37 and 38 °C with
a heating pad. The systolic blood pressure and heart rate
were continuously monitored using a tail-cuff connected
to a pulse transducer device (MLT125/R; AD Instruments,
Castle Hill, Australia). The transducer was connected to a
PowerLab/4SP data acquisition system (Chart, Version 5;
AD Instruments). After removal of the clamps, reperfusion
of the kidneys was visually confirmed. The abdomen was
then sutured in two layers using standard 2/0 sutures.
2.3. Study design
The rats were randomly allocated into 6 groups (n = 5).
Group 1: Sham (n = 5): the rats were subjected to
surgical manipulation without the induction of ischemia.
Group 2: Ischemia/reperfusion (IR) (n = 5): the rats
were subjected to bilateral renal ischemia for 50 min,
followed by 3 days of reperfusion.
Group 3: EPO (n = 5): EPO (1000 IU/kg) was
administered intraperitoneally for 3 days. On day 4, the
rats were subjected to 50 min of ischemia, followed by 3
days of reperfusion.
Group 4: NAC (n = 5): the rats were subjected to 50 min
of ischemia, followed by 3 days of reperfusion. NAC (150
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mg/kg) was administered intraperitoneally by dissolving it
in normal saline for 3 days during the reperfusion period.
Group 5: IPC (n = 5): the rats were subjected to IPC,
which consisted of 3 cycles of 7 min of ischemia, followed
by 7 min of reperfusion, and then subjected to 50 min of
ischemia, followed by 3 days of reperfusion.
Group 6: EPO+IPC+NAC (n = 5): EPO (1000 IU/
kg) was administered for 3 days. On day 4 the rats were
subjected to IPC, which consisted of 3 cycles of 7 min
of ischemia followed by 7 min of reperfusion, and then
subjected to 50 min of ischemia followed by 3 days
of reperfusion. NAC (150 mg/kg) was administered
intraperitoneally from day 4 until day 7.
The rats were then placed in standard cages for the
period of reperfusion. At 24 h before the end of the in vivo
study, the animals were placed in metabolic cages to collect
urine for urinary N-acetyl-β-(D)-glucosaminidase (NAG)
activity evaluation. After 24 h, the rats were anesthetized
and blood samples were obtained from the inferior vena
cava. The rats were euthanized and their kidneys were
harvested before being washed and dissected in cold
normal saline. Part of the kidney was immediately snapfrozen in liquid nitrogen and stored at –70 °C until further
use.
2.4. Renal function and tubular damage assessments
Plasma urea and creatinine levels were estimated using an
autoanalyzer (Hitachi 704 autoanalyzer, Hitachi, Tokyo,
Japan). Urine samples were collected at the end of the 24-h
period and urinary NAG activity was measured on the
basis of enzymatic hydrolysis of p-nitrophenyl-n-acetylglucosaminide using a spectrophotometer.
2.5. Evaluation of the renal oxidative stress
Renal oxidative stress was evaluated by measuring the
activities of antioxidant enzymes superoxide dismutase
(SOD) and catalase (CAT), as well as glutathione (GSH)
levels, in the kidney tissues. Lipid peroxidation was
evaluated by measuring the malondialdehyde (MDA)
content in the kidney tissues.
2.6. Evaluation of the inflammatory markers
Plasma levels of tumor necrosis factor-alpha (TNF-α) and
interleukin-6 (IL-6) were evaluated using a commercial
enzyme-linked immunosorbent assay (ELISA) kit (R&D
Systems Inc., USA).
2.7. Statistical analysis
SPSS 20.0 (IBM Corp., Armonk, NY, USA) was used for
data analysis. Differences among the groups were assessed
with one-way ANOVA and the Tukey HSD test was used
to examine the difference between two groups. Statistical
significance was accepted at P < 0.05; the arithmetic means
± standard errors of the means were used to define the
distribution.
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3. Results
3.1. EPO, IPC, NAC, and their combination attenuated
postischemic renal dysfunction
As demonstrated in Figures 1A and 1B, the renal functional
markers (BUN and Cr) of the animals subjected to IR
showed significant increases compared to the Sham group
(P < 0.05). These markers were significantly improved by
treatment with EPO, IPC, and NAC when compared to the
IR group (P < 0.05). However, in the combination group,
the functional parameters were significantly lower than
in the other treated groups (P < 0.05), suggesting that a
combination of EPO, IPC, and NAC was more effective on
IR-induced renal dysfunction.
3.2. EPO, IPC, NAC, and their combination reduced postischemic tubular damage
In the IR group, urinary NAG activity was significantly
elevated when compared to the Sham group (P < 0.05).
Treatment with EPO, IPC, and NAC alone significantly
reduced tubular damage when compared to the IR group
(P < 0.05). However, in the combination group, the tubular
damage was significantly lower than in the other treated
groups (P < 0.05), suggesting that a combination of EPO,

IPC, and NAC was more effective on IR-induced renal
tubular injury (P < 0.05, Figure 1C).
3.3. EPO, IPC, NAC, and their combination attenuated
postischemic oxidative stress
Renal IR injury significantly decreased the renal tissue
SOD and CAT activities when compared to the Sham
group (P < 0.05). Treatment with EPO, IPC, and NAC
alone resulted in significantly higher activities of SOD and
CAT when compared to the IR group (P < 0.05). However,
the activities of these enzymes were significantly higher in
the combination group than in the other treated groups (P
< 0.05), suggesting that a combination of EPO, IPC, and
NAC was more effective on IR-induced renal oxidative
stress (P < 0.05, Figures 2A and 2B).
The renal tissue GSH level was significantly reduced
in the IR group when compared to the Sham group (P <
0.05). Treatment with EPO, IPC, and NAC alone resulted
in a significantly higher GSH level when compared to the
IR group (P < 0.05). However, the GSH concentration
was significantly higher in the combination group than
in the other treated groups (P < 0.05), suggesting that a
combination of EPO, IPC, and NAC was more effective on
IR-induced renal oxidative stress (P < 0.05, Figure 3A).

Figure 1. Plasma BUN (A) and creatinine (B) levels, and urinary NAG (C) activity. Results are presented as the mean ± standard error
of the mean (SEM); n = 5 in each group: *P ˂ 0.05 vs. Sham group; #P ˂ 0.05 vs. IR group; &P ˂ 0.05 vs. EPO, IPC, and NAC groups.
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Figure 2. Renal tissue SOD (A) and CAT (B) activities. Results are presented as the
mean ± standard error of the mean (SEM); n = 5 in each group: *P ˂ 0.05 vs. Sham
group; #P ˂ 0.05 vs. IR group; &P ˂ 0.05 vs. EPO, IPC, and NAC groups.

Renal IR injury resulted in a significant elevation in
the renal tissue MDA content when compared to the Sham
group (P < 0.05). Treatment with EPO, IPC, and NAC
alone resulted in a significantly lower MDA level when
compared to the IR group (P < 0.05). However, the MDA
concentration was significantly lower in the combination
group than in the other treated groups (P < 0.05),
suggesting that a combination of EPO, IPC, and NAC was
more effective on IR-induced renal oxidative stress (P <
0.05, Figure 3B).
3.4. EPO, IPC, NAC, and their combination suppressed
postischemic inflammatory cytokines
Renal IR injury resulted in significant elevations in plasma
TNF-α and IL-6 when compared to the Sham group (P <
0.05). Treatment with EPO, IPC, and NAC alone resulted in
significantly lower plasma TNF-α and IL-6 when compared
to the IR group (P < 0.05). However, these parameters
were significantly lower in the combination group than
in the other treated groups (P < 0.05), suggesting that the
combination of EPO, IPC, and NAC was more effective on
IR-induced renal (P < 0.05, Figures 4A and 4B).
4. Discussion
Due to the multifactorial nature of IR-induced kidney
damage, this study was designed to investigate the effect
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of concomitant administration of EPO and NAC with an
IPC regimen on renal IR injury. The findings showed that
pretreatment with EPO, IPC insults, and posttreatment
with NAC ameliorated the organ damage in a bilateral
renal IR injury rat model, with the greatest effects seen in
the combination group. The kidney is extremely sensitive
to hypoxia, which makes it vulnerable to ischemic injury.
Oxidative stress is considered as the key step in the
initiation and development of renal IR injury [12]. Severe
oxidative stress can make renal transplantation grafts
highly prone to acute and chronic rejection [13]. Under
these conditions, ROS are produced by the mitochondrial
respiratory chain in the ischemia phase and magnified in
the reperfusion period, which may eventually result in
cell death by directly impairing DNA, proteins, and lipids
[14]. IR injury induces the release of the proinflammatory
cytokines and chemokines from the kidney vasculature
and parenchymal cells [15]. In the present study, renal
functional impairments were evidenced by significantly
increased plasma urea, creatinine, inflammatory cytokines,
urinary NAG activity, and oxidative stress markers, as
well as a significant reduction in renal tissue antioxidant
enzyme activities in the bilateral renal IR group.
EPO is a kidney-derived growth factor that has long
been considered as the stimulating factor for erythropoiesis.
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Figure 3. Renal tissue GSH levels (A) and MDA contents (B). Results are presented as
the mean ± standard error of the mean (SEM); n = 5 in each group: *P ˂ 0.05 vs. Sham
group; #P ˂ 0.05 vs. IR group; &P ˂ 0.05 vs. EPO, IPC, and NAC groups.

However, recent studies have reported that EPO may exert
protective effects against IR injury, by the attenuation
of renal dysfunction, oxidative stress, inﬂammatory
response, and cell death [16,17]. Our results showed that
pretreatment with EPO alone or in combination with IPC
and posttreatment NAC reduced the renal tissue MDA
content and elevated renal tissue SOD and CAT activities
and GSH levels, and then subsequently reduced kidney
dysfunction (plasma urea, Cr, and urinary NAG activity).
These results were consistent with our previous studies,
which demonstrated the antioxidant effects of EPO on
renal IR injury [16]. The antioxidant effect of EPO may be
related to its ability to induce the formation of antioxidant
enzymes, such as hemoxygenase-1 [18] and glutathione
peroxidase [19].
In the current study, pretreatment with EPO alone or in
combination with IPC and NAC significantly suppressed
the plasma levels of proinflammatory cytokines TNF-α
and IL-6. This was in agreement with previous studies,
which demonstrated that EPO treatment suppressed
the inflammatory response in IR injury by reducing
proinflammatory cytokines, such as TNF-α and IL-6
[16,20].
IPC has been shown to have an ameliorative effect on
kidney IR injury due to its antiapoptotic, antiinflammatory,

and antioxidant properties [9,10]. In this study, it was
found that application of IPC alone or in combination with
EPO and NAC significantly attenuated kidney damage.
In agreement with these findings, several studies have
demonstrated the renoprotective effects of IPC on kidney
IR injury [16,21].
TNF-α, in association with IL-17A, induces
the expression of transcriptional IL-6 and other
proinﬂammatory cytokines and participates in an
inﬂammatory response to kidney IR injury [22,23]. TNF-α,
which is expressed in renal tubular cells, participates
in the infiltration of various immune cells to create a
positive feedback cycle of inflammatory response [22].
In the present study, plasma TNF-α and IL-6 levels were
significantly suppressed in the treatment groups when
compared to the IR group, with the greatest effect seen in
the combination group. Consistent with these results, IPC
exhibited a potent antiinﬂammatory capacity to suppress
kidney IR injury by reducing the plasma levels of TNF-α
and IL-6 [24].
In this study, the possible protective effect of
NAC alone or in combination with EPO and IPC was
evaluated. The results demonstrated that posttreatment
with NAC alone or in combination with EPO and IPC
exhibited an attenuation effect on kidney IR injury.
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Figure 4. Plasma TNF-α (A) and IL-6 (B) levels. Results are presented as the mean ± standard error of the
mean (SEM); n = 5 in each group: *P ˂ 0.05 vs. Sham group; #P ˂ 0.05 vs. IR group; &P ˂ 0.05 vs. EPO, IPC,
and NAC groups.

NAC attenuates oxidative stress in renal IR injury by
the direct scavenging of ROS, such as hypochlorous
acid, hydrogen peroxide, superoxide, and the hydroxyl
radical [25], and by the prevention of lipid peroxidation
and protection of GSH contents [26]. In a recent study,
NAC was demonstrated to have ameliorative effects on
renal IR injury [27]. Plasma levels of TNF-α and IL-6
have been widely used as indices for proinflammatory
response. In the present study, posttreatment with
NAC alone or in combination with a pretreatment of
EPO and IPC significantly reduced the plasma levels of
TNF-α and IL-6 when compared to the IR group, with

the greatest effect seen in the combination group. NAC
is a free radical scavenger, which in acute renal injury
has ameliorative effects on inflammatory responses,
such as the inhibition of cytokine expression and the
suppression of NF-κB [28]. In agreement with this study,
the inhibition of proinflammatory cytokines by NAC
was demonstrated in an animal model of acute kidney
injury [27].
In conclusion, these results showed that concomitant
administration of EPO and IPC along with NAC
posttreatment may have an additive beneficial effect on
kidney IR injury during IR-induced acute renal failure.
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